• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Technology

Gene base editing reverses Huntington’s disease in mice

Bioengineer by Bioengineer
July 29, 2026
in Technology
Reading Time: 2 mins read
0
Gene base editing reverses Huntington’s disease in mice
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

CHAMPAIGN, Ill. — Researchers at the University of Illinois Urbana-Champaign report that a precision gene-editing strategy can reduce the toxic protein burden and neurological symptoms of Huntington’s disease in mice. Instead of silencing the HTT gene, the approach reframes treatment as a controlled modification of how the mutant protein is processed inside cells.

Huntington’s disease is driven by a mutation in the HTT gene that makes the huntingtin protein susceptible to cleavage into fragments that accumulate and harm neurons. Because disease onset often occurs in midlife, many people first recognize their condition only after years of biological change, underscoring the need for interventions that can alter disease progression.

The Illinois team employed CRISPR base editing, a DNA-writing method designed to chemically convert one nucleotide to another without creating double-strand breaks. Their base editor targets a specific region within HTT that, when cleaved, helps initiate the cascade leading to the most damaging fragments. By redirecting this processing step, the edited cells avoid producing key toxic species while preserving enough normal huntingtin function for basic biology.

To identify candidates suitable for in vivo use, the researchers screened more than 140 base editors. They selected variants demonstrating the best balance of efficiency and minimal unintended effects, then delivered the most promising editors into the brains of mice carrying mutant HTT genes.

Treated animals showed lower accumulation of toxic huntingtin fragments compared with untreated controls. Behavioral and neurological assessments indicated reduced disease-associated symptoms, alongside less brain degeneration over the study period. The findings collectively support the feasibility of a “processing correction” paradigm for genetic disorders.

Lead investigator Pablo Perez-Pinera emphasized that this work highlights a new way to think about Huntington’s therapy: a small genetic edit can shift protein maturation rather than fully inactivating a gene or broadly disrupting parallel pathways. Thomas Gaj added that the strategy illustrates how modifying protein function through targeted reading changes may be sufficient to limit damage.

The study also suggests a broader platform: base editors may be repurposed to mitigate other genetic diseases by tuning how transcripts are interpreted or how proteins are generated. The work therefore extends the conceptual toolkit beyond one-to-one mutation correction.

Next, the team plans to improve delivery to the brain to reduce invasiveness and minimize reliance on viral transport. Graduate student Kyrollos Shenouda noted that the group is also exploring additional HTT targeting sites to suppress other toxic aspects of the mutant protein.

Subject of Research: Animals
Article Title: In vivo CRISPR base editing for treatment of Huntington’s disease
News Publication Date: 29-Jul-2026
Web References: http://dx.doi.org/10.1038/s41551-026-01747-y
References: Nature Biomedical Engineering; “In vivo CRISPR base editing for treatment of Huntington’s disease” (DOI: 10.1038/s41551-026-01747-y)
Image Credits: Craig Pessman

Keywords

CRISPR base editing; Huntington’s disease; HTT; gene therapy; in vivo brain delivery; neurodegeneration; toxic protein fragments; Nature Biomedical Engineering

Tags: advanced gene editing strategies for neurodegenerative diseasesCRISPR base editing in neurodegenerative diseasesCRISPR-based treatment for Huntington’s diseasegene therapy to prevent neuronal damageHuntington’s disease gene editingin vivo gene therapy for neurological disordersmutant huntingtin protein modificationmutation correction in Huntington’s disease mouse modelsprecision genome editing for neurodegenerationreducing neurotoxicity through DNA base editingtargeted DNA editing to reduce toxic protein accumulationtherapeutic genome editing for late

Share12Tweet7Share2ShareShareShare1

Related Posts

Optimal Recycled Concrete Mix Identified for Structural and Environmental Performance Balance

Optimal Recycled Concrete Mix Identified for Structural and Environmental Performance Balance

November 18, 2026
Encrypted Graph Network Enables Real-Time Fault-Tolerant Medical Device Analytics

Encrypted Graph Network Enables Real-Time Fault-Tolerant Medical Device Analytics

November 18, 2026

Novel Cone Metric Framework Establishes Operator Contractions Without Scalar Smallness Conditions

November 18, 2026

Dense Mudstone Gradations Suppress Embankment Creep by Buffering Fractured Rock Particles

November 18, 2026

POPULAR NEWS

  • Spain NTD Drug Study Reveals Severe Territorial Gaps Across Autonomous Communities

    Spain NTD Drug Study Reveals Severe Territorial Gaps Across Autonomous Communities

    29 shares
    Share 12 Tweet 7
  • Guinea Health Study Reveals Severe Workforce Unemployment Despite Rising Professional Training

    29 shares
    Share 12 Tweet 7
  • Rootstock Signaling Networks Dynamically Reprogram Fruit Quality Across Horticultural Crops

    29 shares
    Share 12 Tweet 7
  • Review Uncovers How Group 2 Innate Lymphoid Cells Bridge Neuroimmune Communication

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Novel CARD11 Gene Variant Causes Atopy and Immunodeficiency in Family

Bedside Ultrasound Is Associated With Shorter Time-to-CT in High-Risk Abdominal Surgery

Study Finds System Barriers For Parents Seeking Healthcare For Children With Disabilities

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.